Xytaz 250mg/31.25mg Injection
Marketer
Laxian Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Xytaz 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administer this injection only under a doctor's direct guidance; strictly adhere to the prescribed dosage schedule. Complete the entire course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; report worsening symptoms promptly. Seek immediate medical attention for allergic reactions like rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications, especially if you are pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. For optimal recovery, prioritize rest, nutrition, and hydration. Your physician may order laboratory tests to monitor treatment response.
Uses of Xytaz 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Xytaz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Xytaz 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xytaz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Xytaz 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg Injection (Xytaz) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xytaz 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Xytaz Injection (250mg/31.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; however, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Xytaz 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Xytaz 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Xytaz 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Administering Xytaz 250mg/31.25mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage changes for Xytaz 250mg/31.25mg Injection are not advised for those with mild or moderate liver dysfunction.
What if you forget to take Xytaz 250mg/31.25mg Injection :
Should you forget a scheduled Xytaz 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Xytaz 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently